GE launches $250M equity fund for healthcare tech firms

Justine Varieur Cadet | | Health Imaging | Artificial Intelligence
GE announced the formation of a new equity fund, the $250 million GE Healthymagination Fund, which will make investments in healthcare technology companies.

The fund will invest in companies globally that have diagnostic, IT and life sciences technologies aligned with GE’s Healthymagination initiative. The fund will also support healthcare companies developing “innovative and unique business models and services.”

The company said the fund’s formation is part of its $6 billion Healthymagination initiative. The fund will target three areas for investment:

  • Broad-based diagnostics, including imaging, home health, patient monitoring, molecular diagnostics, pathology, imaging agents and other technologies for disease diagnosis.
  • Healthcare IT, including EMRs, clinical information systems, healthcare information exchanges and value-added data services.
  • Life Sciences, including tools for R&D in biopharmaceuticals and stem cells, and technologies for the manufacturing of biopharmaceuticals and vaccines.

GE said the fund will draw on capabilities from across GE Healthcare, GE Capital and GE Global Research.

Justine Varieur Cadet

Related Content

New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA
PHOTO GALLERY: Medical imaging technology at RSNA 2024
Cardiology, radiology specialists debate CCTA’s rise as a go-to imaging modality for CAD
Can large language models break language barriers in radiology reports?
Most patients want to know if AI is involved in their care
New algorithm is twice as accurate at predicting stroke timing compared to the standard of care

Around the web

Radiology Business
The biggest challenges facing radiology business managers in 2025

RBMA President Peter Moffatt discusses some of the biggest obstacles facing the specialty in the new year. 

Cardiovascular Business
New cardiac prevention paradigm explored in TRANSFORM trial using AI and CCTA

Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.

Cardiovascular Business
Cardiology practices pay $17.7M to settle fraud allegations brought on by whistleblowers

A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.